Bad Karma - An Analysis of Karmma-3 | Idacel vs 'standard regimens'

Sdílet
Vložit
  • čas přidán 5. 03. 2023
  • Vinay Prasad, MD MPH; Physician & Professor
    Hematologist/ Oncologist
    Professor of Epidemiology, Biostatistics and Medicine
    Author of 450+ Peer Reviewed papers, 2 Books, 2 Podcasts, 100+ op-eds.
    If you want to contact me, do it here: www.vinayakkprasad.com/contact
    Google Scholar: scholar.google.com/citations?...
    Substack: vinayprasadmdmph.substack.com/
    Podcast: podcasts.apple.com/us/podcast...
    Personal Website: www.vinayakkprasad.com
    Laboratory Website: www.vkprasadlab.com
    Podcast Website: www.plenarysessionpodcast.com
    Academic Publications: www.vinayakkprasad.com/papers
    Follow me on:
    Twitter @vprasadmdmph

Komentáře • 17

  • @tada6672
    @tada6672 Před rokem +6

    God FORBID!!👍😎👍🙏😇🙏💞💞💞💞That's why we Love you!! Keep holding them to be RESPONSIBLE.

  • @reginamemoriesforever-vc8ql

    Vinay you are excellent! This podcast is a masterclass on HOW TO THINK

  • @ericschnell9114
    @ericschnell9114 Před rokem +3

    Keep pushing doc! This will be a lifelong battle if you are up for it and it seems you are.

  • @olibertosoto5470
    @olibertosoto5470 Před rokem +2

    It's like what car dealerships have always been - you won't get the real bottom line until you've bought the car.

  • @catiapb1
    @catiapb1 Před rokem +1

    Dark ages of science...

  • @ChrisCapoccia
    @ChrisCapoccia Před rokem +2

    It's not surprising that drug companies are finding tricky ways to report some positive outcome. What is surprising that respected journals like NEJM are publishing uncritically

  • @tallard666
    @tallard666 Před rokem

    @Vinay Tech question.
    this video also plays directly from the Letters page, without any youtube link as we normally see. Also, the video on your letters page keeps buffering whereas here on yt it plays just fine.

  • @warlorth
    @warlorth Před rokem

    I enjoy your content thoroughly, excellent review, perhaps i am looking at this wrong, and i welcome correction, but question regarding the LocoMMotion study, those patients did not receive CAR-T but it appears in KarMMa-3 60 patients who were on the standard regimen therapy went on to receive Ide-cel, is it possible the longer OS seen in standard arm is primarily related to their access to CAR-T?

  • @Karma-fp7ho
    @Karma-fp7ho Před rokem

    Here in BC we still have 30% excess deaths in the under 45 age group. What is going on?

  • @oldmango8606
    @oldmango8606 Před rokem +1

    give them hell Harry. thanx

  • @seandejesus623
    @seandejesus623 Před rokem +2

    1st

    • @JCResDoc94
      @JCResDoc94 Před rokem +1

      ive nvr done a 1st. but the classic nvr dxe. 3rd. _JC

  • @derangstgarten1447
    @derangstgarten1447 Před rokem

    Bad karma?
    FOUL CHI
    lol